S&P 500   3,253.21 (-1.28%)
DOW   28,614.04 (-1.30%)
QQQ   218.82 (-1.74%)
AAPL   310.58 (-2.43%)
FB   215.39 (-1.17%)
MSFT   162.71 (-1.41%)
GOOGL   1,432.36 (-2.31%)
AMZN   1,835.01 (-1.43%)
CGC   21.81 (-3.71%)
NVDA   241.45 (-3.61%)
BABA   206.25 (-3.51%)
MU   55.85 (-3.31%)
GE   11.48 (-1.96%)
TSLA   559.05 (-1.02%)
T   38.44 (-0.16%)
ACB   1.91 (-4.03%)
F   8.93 (-0.78%)
PRI   119.81 (-2.22%)
BAC   32.92 (-1.85%)
DIS   136.23 (-2.75%)
S&P 500   3,253.21 (-1.28%)
DOW   28,614.04 (-1.30%)
QQQ   218.82 (-1.74%)
AAPL   310.58 (-2.43%)
FB   215.39 (-1.17%)
MSFT   162.71 (-1.41%)
GOOGL   1,432.36 (-2.31%)
AMZN   1,835.01 (-1.43%)
CGC   21.81 (-3.71%)
NVDA   241.45 (-3.61%)
BABA   206.25 (-3.51%)
MU   55.85 (-3.31%)
GE   11.48 (-1.96%)
TSLA   559.05 (-1.02%)
T   38.44 (-0.16%)
ACB   1.91 (-4.03%)
F   8.93 (-0.78%)
PRI   119.81 (-2.22%)
BAC   32.92 (-1.85%)
DIS   136.23 (-2.75%)
S&P 500   3,253.21 (-1.28%)
DOW   28,614.04 (-1.30%)
QQQ   218.82 (-1.74%)
AAPL   310.58 (-2.43%)
FB   215.39 (-1.17%)
MSFT   162.71 (-1.41%)
GOOGL   1,432.36 (-2.31%)
AMZN   1,835.01 (-1.43%)
CGC   21.81 (-3.71%)
NVDA   241.45 (-3.61%)
BABA   206.25 (-3.51%)
MU   55.85 (-3.31%)
GE   11.48 (-1.96%)
TSLA   559.05 (-1.02%)
T   38.44 (-0.16%)
ACB   1.91 (-4.03%)
F   8.93 (-0.78%)
PRI   119.81 (-2.22%)
BAC   32.92 (-1.85%)
DIS   136.23 (-2.75%)
S&P 500   3,253.21 (-1.28%)
DOW   28,614.04 (-1.30%)
QQQ   218.82 (-1.74%)
AAPL   310.58 (-2.43%)
FB   215.39 (-1.17%)
MSFT   162.71 (-1.41%)
GOOGL   1,432.36 (-2.31%)
AMZN   1,835.01 (-1.43%)
CGC   21.81 (-3.71%)
NVDA   241.45 (-3.61%)
BABA   206.25 (-3.51%)
MU   55.85 (-3.31%)
GE   11.48 (-1.96%)
TSLA   559.05 (-1.02%)
T   38.44 (-0.16%)
ACB   1.91 (-4.03%)
F   8.93 (-0.78%)
PRI   119.81 (-2.22%)
BAC   32.92 (-1.85%)
DIS   136.23 (-2.75%)
Log in

NASDAQ:BIOL - BIOLASE Stock Price, Forecast & News

$0.78
-0.02 (-2.50 %)
(As of 01/27/2020 02:44 PM ET)
Today's Range
$0.73
Now: $0.78
$0.79
50-Day Range
$0.47
MA: $0.59
$0.87
52-Week Range
$0.43
Now: $0.78
$2.87
Volume5,811 shs
Average Volume209,279 shs
Market Capitalization$24.14 million
P/E RatioN/A
Dividend YieldN/A
Beta2.16
BIOLASE, Inc, a medical device company, develops, manufactures, markets, and sells laser systems in dentistry and medicine for patients and health care professionals in the worldwide. The company offers Waterlase all-tissue dental laser systems for cutting soft and hard tissues; and diode laser systems to perform soft tissue, pain therapy, and cosmetic procedures, including teeth whitening. Read More…

Industry, Sector and Symbol

Industry Dental equipment & supplies
Sub-IndustryN/A
SectorMedical
Current SymbolNASDAQ:BIOL
Previous SymbolNASDAQ:BLTI
CUSIPN/A
Phone949-361-1200

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$46.15 million
Book Value$0.54 per share

Profitability

Net Income$-21,520,000.00

Miscellaneous

Employees190
Market Cap$24.14 million
Next Earnings Date3/3/2020 (Estimated)
OptionableNot Optionable

Receive BIOL News and Ratings via Email

Sign-up to receive the latest news and ratings for BIOL and its competitors with MarketBeat's FREE daily newsletter.


BIOLASE (NASDAQ:BIOL) Frequently Asked Questions

What is BIOLASE's stock symbol?

BIOLASE trades on the NASDAQ under the ticker symbol "BIOL."

When did BIOLASE's stock split? How did BIOLASE's stock split work?

BIOLASE's stock reverse split on Friday, May 11th 2018. The 1-5 reverse split was announced on Thursday, May 10th 2018. The number of shares owned by shareholders was adjusted after the market closes on Thursday, May 10th 2018. An investor that had 100 shares of BIOLASE stock prior to the reverse split would have 20 shares after the split.

How were BIOLASE's earnings last quarter?

BIOLASE Inc (NASDAQ:BIOL) announced its quarterly earnings data on Wednesday, November, 6th. The medical technology company reported ($0.12) EPS for the quarter, beating the Zacks' consensus estimate of ($0.25) by $0.13. The medical technology company had revenue of $8.65 million for the quarter. BIOLASE had a negative return on equity of 313.64% and a negative net margin of 52.13%. View BIOLASE's Earnings History.

When is BIOLASE's next earnings date?

BIOLASE is scheduled to release their next quarterly earnings announcement on Tuesday, March 3rd 2020. View Earnings Estimates for BIOLASE.

What price target have analysts set for BIOL?

4 Wall Street analysts have issued 1 year price targets for BIOLASE's shares. Their forecasts range from $2.00 to $3.00. On average, they anticipate BIOLASE's stock price to reach $2.50 in the next year. This suggests a possible upside of 220.5% from the stock's current price. View Analyst Price Targets for BIOLASE.

What is the consensus analysts' recommendation for BIOLASE?

4 Wall Street analysts have issued "buy," "hold," and "sell" ratings for BIOLASE in the last year. There are currently 1 hold rating and 3 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for BIOLASE.

Has BIOLASE been receiving favorable news coverage?

Press coverage about BIOL stock has been trending somewhat negative this week, InfoTrie reports. The research group ranks the sentiment of media coverage by monitoring more than six thousand blog and news sources in real time. The firm ranks coverage of public companies on a scale of -5 to 5, with scores closest to five being the most favorable. BIOLASE earned a daily sentiment score of -1.4 on InfoTrie's scale. They also gave news headlines about the medical technology company a news buzz of 0.0 out of 10, meaning that recent media coverage is extremely unlikely to have an effect on the company's share price in the next few days. View News Stories for BIOLASE.

Who are some of BIOLASE's key competitors?

What other stocks do shareholders of BIOLASE own?

Who are BIOLASE's key executives?

BIOLASE's management team includes the folowing people:
  • Mr. Todd A. Norbe, Pres, CEO & Director (Age 52)
  • Mr. John R. Beaver, Exec. VP & CFO (Age 58)
  • Mr. Richard R. Whipp, VP of Operations (Age 67)
  • Mr. William E. Brown Jr., VP of Bus. Devel. (Age 71)
  • Mr. Daniel Merkin, National Sales Director (Age 46)

How do I buy shares of BIOLASE?

Shares of BIOL can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is BIOLASE's stock price today?

One share of BIOL stock can currently be purchased for approximately $0.78.

How big of a company is BIOLASE?

BIOLASE has a market capitalization of $24.14 million and generates $46.15 million in revenue each year. The medical technology company earns $-21,520,000.00 in net income (profit) each year or ($0.85) on an earnings per share basis. BIOLASE employs 190 workers across the globe.View Additional Information About BIOLASE.

What is BIOLASE's official website?

The official website for BIOLASE is http://www.biolase.com/.

How can I contact BIOLASE?

BIOLASE's mailing address is 4 Cromwell, Irvine CA, 92618. The medical technology company can be reached via phone at 949-361-1200 or via email at [email protected]


MarketBeat Community Rating for BIOLASE (NASDAQ BIOL)

Community Ranking:  2.5 out of 5 (star star half star)
Outperform Votes:  253 (Vote Outperform)
Underperform Votes:  251 (Vote Underperform)
Total Votes:  504
MarketBeat's community ratings are surveys of what our community members think about BIOLASE and other stocks. Vote "Outperform" if you believe BIOL will outperform the S&P 500 over the long term. Vote "Underperform" if you believe BIOL will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 1/27/2020 by MarketBeat.com Staff

Featured Article: Beige Book

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel